Actively Recruiting

Age: 60Years - 120Years
All Genders
Healthy Volunteers
ID07124949

Chinese Migrant Population Health Cohort

Led by Jinwei Tian · Updated on 2025-08-20

26000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

J

Jinwei Tian

Lead Sponsor

H

Hainan Medical College

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are conducting the Chinese Migrant Population Health Cohort, a prospective multi-center study focusing on adults aged 60 years and older who seasonally migrate between cold (Heilongjiang) and tropical (Hainan) regions. The study aims to understand the risks of cardiovascular and metabolic diseases in this population, explore underlying biological and environmental causes, and identify effective prevention strategies. This is the first study in China to systematically examine how seasonal migration affects older adults' health by integrating epidemiology, multi-omics, environmental data, and health policy translation. Participants are recruited from both their origin and destination locations and undergo comprehensive baseline assessments including questionnaires, physical exams, medical imaging, biospecimen collection (blood, stool, hair, nails), and monitoring of environmental exposures. The cohort includes groups such as winter migrants, summer migrants, cold-region residents, and tropical-region residents, all followed over time without any intervention. The study also plans to use artificial intelligence to develop risk prediction models and nested randomized controlled trials to evaluate targeted interventions. During the study, participants will have periodic reassessments, remote monitoring, and data linkage with hospital records to track health outcomes over up to five years. Researchers will measure events like the first major cardiovascular incident, new metabolic disorders, deaths, changes in cardiometabolic risk factors, quality of life, and cognitive function. Participants' ability to complete questionnaires and physical exams is monitored, with long-term follow-up and biospecimen collection to support the research into disease mechanisms and health management.

CONDITIONS

Brief Title

Chinese Migrant Population Health Cohort

Who Can Participate

Age: 60Years - 120Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Permanent residents of Harbin or Hainan planning to live there for the next 5 years
  • Age 60 years or older with basic communication and comprehension abilities
  • No confirmed diagnosis of end-stage major organic diseases such as advanced heart failure, advanced liver failure, advanced kidney failure, or malignant tumors
  • Able to perform daily activities independently and complete questionnaires and physical exams
  • Willing to provide written consent, participate in long-term follow-up, and provide biological specimens
Not Eligible

You will not qualify if you...

  • Experienced life-threatening acute events like myocardial infarction, acute heart failure, or stroke within the past 30 days
  • Currently receiving chronic antiviral or antipsychotic treatment
  • Moderate to severe cognitive impairment preventing survey completion or follow-up
  • Acute infectious diseases such as influenza or fever at the time of screening
  • Participating in other interventional clinical studies
  • Refusal to provide informed consent or biological specimens
  • Any condition deemed unsuitable by investigators based on overall assessment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Baseline

Participants undergo initial assessments including questionnaires, physical exams, and biological specimen collection.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 5 years

Participants are monitored to track cardiovascular events, metabolic disorders, quality of life, and cognitive function over time without intervention.

Assessments at 2 years and 4 years after baseline

Trial Site Locations

Total: 1 location

1

Harbin Medical University

Harbin, Heilongjiang, China, 150086,

Actively Recruiting

Loading map...

Research Team

J

Jinwei Tian, Ph.D.

C

Cheng Jin, Ph.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Similar Trials

Multifactorial Risk Stratification in Acute and Chronic Card...

Cardiovascular Diseases

Actively Recruiting

2 locations

Beneficial Effects of Perfect Heartio Drink in Improving Car...

Cardiovascular Diseases

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Projecting future risk of dengue related to hydrometeorological conditions in mainland China under climate change scenarios: a modelling study.

Chuanxi Li, Zhao Liu, Wen Li...

https://pubmed.ncbi.nlm.nih.gov/37164516

The 2023 report of the Lancet Countdown on health and climate change: the imperative for a health-centred response in a world facing irreversible harms.

Marina Romanello, Claudia di Napoli, Carole Green...

https://pubmed.ncbi.nlm.nih.gov/37977174

Healthcare system resilience in Bangladesh and Haiti in times of global changes (climate-related events, migration and Covid-19): an interdisciplinary mixed method research protocol.

Lucie Clech, Sofia Meister, Maeva Belloiseau...

https://pubmed.ncbi.nlm.nih.gov/35291985

Climate Change and Ambient Temperature Extremes: Association With Serious Hypoglycemia, Diabetic Ketoacidosis, and Sudden Cardiac Arrest/Ventricular Arrhythmia in People With Type 2 Diabetes.

Kacie Bogar, Colleen M Brensinger, Sean Hennessy...

https://pubmed.ncbi.nlm.nih.gov/36205432